Patents by Inventor Yuki Akiyoshi

Yuki Akiyoshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING PROGNOSIS OF ACUTE CENTRAL NERVOUS SYSTEM DISORDER
    Publication number: 20120052592
    Abstract: The present invention has its main object of providing a method for determining prognosis scientifically by searching an early marker for predicting neurological prognosis in order to grasp the disease state of a patient with an acute central nervous system disorder in the early stage and enabling an appropriate treatment to be performed. The method for determining the prognosis is provided in which the expression level of SH3BGRL3 in the biological fluid of the patient within 48 hours after resuscitation from cardiopulmonary arrest is measured, and the prognosis of the disorder classified into a good prognosis group and a poor prognosis group depending on the expression level or the presence or absence of the expression based on the Glasgow Outcome Scale (GOS) is predicted.
    Type: Application
    Filed: March 27, 2008
    Publication date: March 1, 2012
    Applicants: NANO SOLUTION, INC.,, YAMAGUCHI UNIVERSITY
    Inventors: Tsuyoshi Maekawa, Tomonori Izumi, Yasutaka Oda, Yuki Akiyoshi
  • METHOD FOR DETERMINING PROGNOSIS OF ACUTE CENTRAL NERVOUS SYSTEM DISORDER
    Publication number: 20110065205
    Abstract: The present invention has its main object of providing a method for determining prognosis scientifically by searching an early marker for predicting neurological prognosis in order to grasp the disease state of a patient with an acute central nervous system disorder in the early stage and enabling an appropriate treatment to be performed. The method for determining the prognosis is provided in which the expression level of SH3BGRL3 in the biological fluid of the patient within 48 hours after resuscitation from cardiopulmonary arrest is measured, and the prognosis of the disorder classified into a good prognosis group and a poor prognosis group depending on the expression level or the presence or absence of the expression based on the Glasgow Outcome Scale (GOS) is predicted.
    Type: Application
    Filed: March 27, 2008
    Publication date: March 17, 2011
    Applicants: YAMAGUCHI UNIVERSITY, NANO SOLUTION, INC.,
    Inventors: Tsuyoshi Maekawa, Tomonori Izumi, Yasutaka Oda, Yuki Akiyoshi